The Prestige Economy
Science has become mired in bureaucracy. Funding is centralized and incentives are misaligned. Government funding has a bias for low-risk work, and scientists waste untold centuries of their time navigating inefficient bureaucracies to get it.
Citations in reputable journals and the buzz around promising new theories are the currency of the scientific world. They influence careers and shape the reputation of institutions. But this metaphorical currency lacks one of the main virtues of real money: it cannot provide returns on the considerable capital investment required to produce science.
But what if we could harness the power of these incentives more directly? What if we made this implicit currency tangible, creating a true market for ideas?
What prestige gets right
In the absence of direct financial markets, the scientific community has evolved a complex system where prestige and reputation serve as the primary currencies. The desire to make a significant contribution, to have one's work recognized and respected by peers, is a powerful motivator. And even with the flaws of peer review, the community maintains a strong emphasis on rigor: researchers with strong reputations have more to lose, and work published under their names faces heightened scrutiny.
This system is far from perfect, but its informal mechanisms contribute significantly to the functioning of science. As we consider reforms, it will be crucial to preserve its strengths while addressing its weaknesses.
Quantity over quality
The pressure to “publish or perish” incentivizes researchers to focus on rapid publication of findings, often at the expense of comprehensive, in-depth studies. A single research project might be fragmented into multiple smaller publications, each aiming to be the “smallest publishable unit.” While this strategy can inflate a scientist's publication count, it risks diluting the potential impact of their overall work.
There's a clear market analogy: imagine a company judged solely on the number of products launched, regardless of whether those products succeed. Such a company would be incentivized to churn out mediocre offerings rather than invest in truly innovative breakthroughs. In academia, the negative consequences of prioritizing quantity may be slower to emerge, but they are no less damaging to the progress of science.
The neglect of replication
Replication, the independent verification of previous scientific findings, is a cornerstone of the scientific method. Robust research should be reproducible by others, enhancing confidence in the results and helping weed out errors or flukes. Yet the current incentive structures in academia often discourage it. Top-tier journals prioritize novel findings, so replications, even when successful, are often considered less exciting or groundbreaking. Securing funding for them is difficult, and the time spent on replication is time not spent on new projects that could yield publications more crucial for career advancement.
The consequences are real. Without rigorous replication, findings deemed “truths” are later overturned, undermining public trust in science, and research efforts get built on flawed foundations, leading to dead ends and the misallocation of resources.
Undermining data collection
The collection and curation of large datasets is a cornerstone of modern scientific research. From genomic databases to climate models, countless discoveries depend on the availability of reliable and well-documented data. However, the current academic landscape often undervalues these labor-intensive contributions. The prestige flows towards researchers who analyze existing datasets to produce novel findings, while those who painstakingly gather the raw data receive less recognition, even if their work is essential.
Unlike financial markets, where profits from a successful venture can be shared with those who supplied vital resources, the prestige attached to an influential 'ideas' paper does not automatically flow back to the data collectors. This creates a fundamental mismatch between those who reap the greatest rewards and those whose labor underpins the entire endeavor.
Bad writing
A large proportion of scientific and academic writing is unreadable. The spread of fancy language to impress peer reviewers and editors makes it harder for scientists to stay apprised of the latest developments in their field and especially for different fields to talk to each other. While some use of jargon is necessary to concisely convey difficult concepts, it often functions as a shibboleth. I suspect that incomprehensible prose that overuses buzzwords and jargon is more useful in getting published than in getting read and cited. Prestigious journals want to sound sophisticated, and peer reviewers may be less likely to disagree with authors or notice problems when everything is gilded in the highest register of jargon-laden scientific language.
Beyond the laboratory
While personal ambition keeps scientists reasonably well aligned with good science, the further prestige is abstracted from the core work of discovery, the more susceptible it becomes to misaligned incentives.
For universities, the prestige associated with groundbreaking research has become a commodity in its own right. Luring established Nobel Laureates or highly cited scientists offers a shortcut to boosting an institution's reputation, compared to the slower and less predictable path of nurturing talent from within. Publications and grant dollars become ends in themselves, rather than proxies for scientific excellence.
Funders are worse. Government agencies face scrutiny for how taxpayer money is spent, which leads to favoring “safer” projects and a reluctance to fund unconventional ideas, even if they hold immense potential. Studies analyzing grant portfolios reveal a systemic bias toward safe projects that incrementally build upon existing knowledge, rather than truly radical ideas. And when scientists are given the freedom and flexibility to fail, as at HHMI, they pursue higher-risk, higher-reward research. Meanwhile, researchers spend upwards of a third of their working hours on grant-related administrative tasks.
Excessive bureaucracy is inevitable in any organization in which the costs to agents of failure or scandal are disproportionately larger than the rewards for success. In contrast, participants in capital markets often face opposite incentives, especially in risky fields such as venture capital: failure is quickly excused and sometimes even celebrated as the inevitable cost of success, while success is richly rewarded.
Traditional scientific publishing is an abomination
The traditional model of scientific publishing presents a paradox. Breakthroughs often stem from taxpayer-funded research, and dedicated scientists volunteer their expertise through peer review. Yet private journals control access to this publicly generated knowledge, charging exorbitant fees that strain university budgets and exclude the very public who supported the work. Meanwhile, authors receive no direct financial benefit, signing over the copyright to journals, who fund themselves by monopolizing the public good of access to science. It is outrageous that journals get away with privatizing the public good of science, but they do, and it is a $20 billion industry.
Where are the venture capitalists of science?
In its essence, science is just as winner-take-all as capitalism; the most cited authors and papers dominate their fields much as the most profitable companies dominate their markets, but while capitalists have developed quite efficient funding mechanisms to align with this reality, science is still stuck with central planning.
Next: Science as an Asset Class